Mephenytoin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for mephenytoin and what is the scope of freedom to operate?
Mephenytoin
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for mephenytoin
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 3 |
Patent Applications: | 4,256 |
Formulation / Manufacturing: | see details |
DailyMed Link: | mephenytoin at DailyMed |
Recent Clinical Trials for mephenytoin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cheng-Kung University Hospital | Phase 4 |
Hamamatsu University | Phase 3 |
Yokoyama Foundation for Clinical Pharmacology | Phase 3 |
Medical Subject Heading (MeSH) Categories for mephenytoin
Anatomical Therapeutic Chemical (ATC) Classes for mephenytoin
US Patents and Regulatory Information for mephenytoin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | MESANTOIN | mephenytoin | TABLET;ORAL | 006008-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |